ProShare Advisors
ETNB

ProShare Advisors’s 89bio ETNB Stock Holding History

ProShare Advisors’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-45,614
Closed -$671K – 2053
2025
Q3 		$671K Buy
45,614
+14,569
+47% +$149K ﹤0.01% 958
2025
Q2 		$305K Buy
31,045
+235
+0.8% +$1.95K ﹤0.01% 1431
2025
Q1 		$224K Buy
30,810
+1,661
+6% +$14.5K ﹤0.01% 1616
2024
Q4 		$228K Buy
29,149
+7,070
+32% +$58.2K ﹤0.01% 1822
2024
Q3 		$163K Buy
22,079
+5,415
+32% +$45.5K ﹤0.01% 1781
2024
Q2 		$133K Sell
16,664
-4,073
-20% -$36.4K ﹤0.01% 1614
2024
Q1 		$241K Buy
20,737
+5,319
+34% +$58.9K ﹤0.01% 1557
2023
Q4 		$172K Buy
15,418
+2,449
+19% +$22.5K ﹤0.01% 1675
2023
Q3 		$200K Buy
12,969
+214
+2% +$3.59K ﹤0.01% 1467
2023
Q2 		$242K Buy
+12,755
New +$224K ﹤0.01% 1425

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ProShare Advisors's ETNB Position: Q4 2025 in Review

ProShare Advisors sold out of 89bio (ETNB) in Q4 2025, closing a stake of 45,614 shares — an estimated $671K sold.

ProShare Advisors first reported a position in ETNB in Q2 2023 and held it in 10 quarters. The position peaked at $671K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • ProShare Advisors reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • ProShare Advisors sold 45,614 89bio shares in Q4 2025, an estimated $671K.
  • ProShare Advisors first reported a position in 89bio in Q2 2023 and held it in 10 quarters.
  • ProShare Advisors's 89bio position peaked at $671K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.